AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Genentech (TECENTRIQ) (tecentriq.com)
Regulated medical substance wrapped in a thick layer of emotional pharmaceutical clichés and lifestyle marketing. While the clinical specifications are high-substance, the presentation relies on trust theatre and heavy repetition of mandatory safety data. It is a textbook example of a site that is legally compliant but functionally bloated with marketing air.
Replace lifestyle H1s like Bedtime Rituals… with specific therapeutic outcomes or patient eligibility summaries to increase immediate information density. Add direct outbound links to ClinicalTrials.gov for the specific trials mentioned to resolve the proof_links_count deficit. Implement Person schema for the medical professionals who authored or reviewed the treatment guides. Include actual efficacy statistics, such as progression-free survival rates, directly in the sub-page hero sections to ground emotional claims in data.
The sub-page H1 headings like Bedtime Rituals… and Weekends In The Workshop, Continued are 100% fluff, using emotional resonance rather than technical nouns. In contrast, the body text is saturated with high-substance medical criteria such as BRAF V600+ advanced melanoma and PD-L1 positive biomarkers. The concept repetition is high, as mandatory safety information blocks are restated on every page, which significantly inflates the fluff-to-new-information ratio. Despite the technical density of the indications, the lifestyle marketing layer creates a barrier of generic language.
Parameter drift, trailing slash inconsistencies, and language leaks create unintended alternate identities. Get a Clinical Canonical Diagnosis to reveal where duplicate embeddings are silently created.
The homepage H1 TECENTRIQ MAY WORK WITH YOUR IMMUNE SYSTEM TO FIGHT CANCER provides a direct and accurate signal for the content found on sub-pages. Each sub-page for HCC, SCLC, and Melanoma delivers specific diagnostic indications that align perfectly with the high-level promise of immunotherapy. There is no evidence of identity shifts or target audience contradictions across the pages, as the focus remains strictly on patients and healthcare professionals. The hierarchy remains consistent, moving logically from broad therapeutic claims to granular patient eligibility requirements.
Identify the current state and friction diagnosis of your specific business model. Generate your Executive SEO Strategy to quantify the financial or conversion cost of strategic misalignment.
The analysis detects a review_count of 2 across all pages while the proof_links_count remains at 0, which triggers the trust_theatre_flag for displaying feedback without external verification. While the site references FDA approval, it fails to provide direct outbound proof paths to external clinical trial registries or peer-reviewed journal publications within the evaluated text. This reliance on the brand’s established authority without providing accessible verification links constitutes moderate trust theatre in a pharmaceutical context.
Proof points are highly concentrated in the Indications and Important Safety Information sections, citing specific gene mutations and cancer stages. The ratio of verifiable medical evidence to vague assertions is high due to stringent FDA reporting requirements for drug manufacturers. However, the site suffers from a total absence of external proof paths in the metadata, as proof_links_count is 0 across all evaluated URLs despite the heavy clinical claims.
To see how the system reconstructs a medical entity graph at scale, review the full Cleveland Clinic Structured Data audit. View the Cleveland Clinic Structured Data Audit for a live example of identity level decomposition and cross page entity mapping.
The value proposition phrase small moments mean so much is a classic industry cliché used to humanize pharmaceutical products through emotional manipulation. Template fingerprints are visible in the Important Safety Information blocks, which are identical across all treatment pages and represent generic boilerplate sections. While the technical drug description is unique to atezolizumab, the How it is thought to work sections use generic mechanism-of-action language. The emotional imagery of workshops and catch-ups could be copy-pasted onto any oncology competitor’s site with no loss in meaning.
The site identifies the Organization as Genentech via schema_json but lacks Person schema for individual medical experts or clinical investigators. While the brand itself holds significant authority, there is no digital footprint provided for the specific clinical leads or medical reviewers responsible for the content accuracy. The technical implementation is robust with a clean heading hierarchy, but the lack of sameAs links to external regulatory profiles for the drug itself is a minor gap in authority mapping.
The site makes significant efficacy claims, such as helps your immune system recognize, target, and attack your cancer, without displaying direct outcome percentages or survival metrics in the main body text. The marketing tone shifts abruptly from clinical specifications to emotional fluff in headings like Morning catch-ups. Evidence for the performance of the drug is largely relegated to references for Full Prescribing Information rather than being demonstrated through accessible data visualizations on the pages.
Medical Devices, Pharma & Biotech BS: Genentech (TECENTRIQ) (tecentriq.com)
The website is a perfect match for the Pharma & Biotech industry, specifically focusing on oncology immunotherapy. The content is heavily regulated and technical, matching the expected profiles for atezolizumab treatment guidelines.
Every retrieval error rooted in "wrong page surfaced" begins with one failure: unstable URL identity. Read the URL & Canonical Technical Guide to learn how consistent paths and canonical alignment preserve semantic cohesion.
“The BS score of 31 is primarily driven by the Trust and Proof pillar and Information Density. The trust_theatre_flag was triggered by the presence of unverified reviews and a lack of outbound proof links. Information density points were added for the 100% fluff H1s on sub-pages and the high level of concept repetition across the site.”
Analysis Disclosure & Source Attribution
Snapshot Date: June 19, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Genentech (TECENTRIQ) to view the most current version of their content and see directly what the company offers.